188 related articles for article (PubMed ID: 22132227)
1. Design and analysis of rhesus cytomegalovirus IL-10 mutants as a model for novel vaccines against human cytomegalovirus.
Logsdon NJ; Eberhardt MK; Allen CE; Barry PA; Walter MR
PLoS One; 2011; 6(11):e28127. PubMed ID: 22132227
[TBL] [Abstract][Full Text] [Related]
2. Host immune responses to a viral immune modulating protein: immunogenicity of viral interleukin-10 in rhesus cytomegalovirus-infected rhesus macaques.
Eberhardt MK; Chang WL; Logsdon NJ; Yue Y; Walter MR; Barry PA
PLoS One; 2012; 7(5):e37931. PubMed ID: 22655082
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against a virus-encoded cytokine significantly restricts viral challenge.
Eberhardt MK; Deshpande A; Chang WL; Barthold SW; Walter MR; Barry PA
J Virol; 2013 Nov; 87(21):11323-31. PubMed ID: 23946461
[TBL] [Abstract][Full Text] [Related]
4. Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
Eberhardt MK; Deshpande A; Fike J; Short R; Schmidt KA; Blozis SA; Walter MR; Barry PA
J Virol; 2016 Nov; 90(21):9920-9930. PubMed ID: 27558431
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity.
Chang WL; Barry PA
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22647-52. PubMed ID: 21149711
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.
Brodeur ND; Spencer JV
Virus Res; 2010 Nov; 153(2):265-8. PubMed ID: 20728483
[TBL] [Abstract][Full Text] [Related]
8. Detection of Cytomegalovirus Interleukin 10 (cmvIL-10) by Enzyme-Linked Immunosorbent Assay (ELISA).
Young VP; Mariano MC; Faure L; Spencer JV
Methods Mol Biol; 2021; 2244():291-299. PubMed ID: 33555593
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques.
Yue Y; Chang WLW; Li J; Nguyen N; Schmidt KA; Dormitzer PR; Yang X; Barry PA
J Virol; 2022 Feb; 96(3):e0165321. PubMed ID: 34788083
[TBL] [Abstract][Full Text] [Related]
10. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
11. Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
Yue Y; Kaur A; Zhou SS; Barry PA
J Gen Virol; 2006 Apr; 87(Pt 4):777-787. PubMed ID: 16528025
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.
Yue Y; Kaur A; Eberhardt MK; Kassis N; Zhou SS; Tarantal AF; Barry PA
J Virol; 2007 Feb; 81(3):1095-109. PubMed ID: 17108040
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.
Young VP; Mariano MC; Tu CC; Allaire KM; Avdic S; Slobedman B; Spencer JV
J Infect Dis; 2017 Mar; 215(6):874-882. PubMed ID: 28453840
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus interleukin-10 expression in infected cells does not impair MHC class I restricted peptide presentation on bystanding antigen-presenting cells.
Pepperl-Klindworth S; Besold K; Frankenberg N; Farkas M; Kuball J; Theobald M; Plachter B
Viral Immunol; 2006; 19(1):92-101. PubMed ID: 16553554
[TBL] [Abstract][Full Text] [Related]
15. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
Yue Y; Barry PA
Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492
[TBL] [Abstract][Full Text] [Related]
16. A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.
Wussow F; Yue Y; Martinez J; Deere JD; Longmate J; Herrmann A; Barry PA; Diamond DJ
J Virol; 2013 Feb; 87(3):1322-32. PubMed ID: 23152525
[TBL] [Abstract][Full Text] [Related]
17. Human Cytomegalovirus-Encoded Human Interleukin-10 (IL-10) Homolog Amplifies Its Immunomodulatory Potential by Upregulating Human IL-10 in Monocytes.
Avdic S; McSharry BP; Steain M; Poole E; Sinclair J; Abendroth A; Slobedman B
J Virol; 2016 Apr; 90(8):3819-3827. PubMed ID: 26792743
[TBL] [Abstract][Full Text] [Related]
18. Characterization of specific antibodies against cytomegalovirus (CMV)-encoded interleukin 10 produced by 28% of CMV-seropositive blood donors.
de Lemos Rieper C; Galle P; Pedersen BK; Hansen MB
J Gen Virol; 2011 Jul; 92(Pt 7):1508-1518. PubMed ID: 21402594
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
20. Exploiting viral natural history for vaccine development.
Barry PA
Med Microbiol Immunol; 2015 Jun; 204(3):255-62. PubMed ID: 25794555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
